Clinical aspects of systemic amyloid diseases
L Obici, V Perfetti, G Palladini, R Moratti… - Biochimica et Biophysica …, 2005 - Elsevier
Amyloidosis is a protein misfolding disorder in which soluble proteins aggregate as insoluble
amyloid fibrils. Protein aggregates and amyloid fibrils cause functional and structural organ …
amyloid fibrils. Protein aggregates and amyloid fibrils cause functional and structural organ …
Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies
R Albertini, R Moratti, G Luca - Current molecular medicine, 2002 - ingentaconnect.com
Although it has been known for long time that atherosclerosis is associated with lipid
deposition, only recently it has been accepted that the plasmatic concentration of cholesterol, …
deposition, only recently it has been accepted that the plasmatic concentration of cholesterol, …
Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction
…, L Goffredo, A Bertoletti, C Klersy, A Pecci, R Moratti… - Blood, 2005 - ashpublications.org
Endothelial progenitor cell (EPC) mobilization has been reported following tissue damage,
whereas no data are available regarding the mobilization of hematopoietic progenitor cells (…
whereas no data are available regarding the mobilization of hematopoietic progenitor cells (…
Serum N-terminal pro–brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis
…, S Perlini, L Obici, E Ascari, GM d'Eril, R Moratti… - Circulation, 2003 - Am Heart Assoc
Background— Brain natriuretic peptide (BNP) is a marker of ventricular dysfunction and can
be used to assess prognosis in heart failure and after myocardial infarction. Heart …
be used to assess prognosis in heart failure and after myocardial infarction. Heart …
Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure
…, R Ferrari, A Fucili, R Moratti, R Tramarin… - European heart …, 2005 - academic.oup.com
Aims Anaemia is often observed in patients with chronic heart failure (CHF), and it may be
associated with a worse prognosis. Aim of this study was to identify the individual mechanisms …
associated with a worse prognosis. Aim of this study was to identify the individual mechanisms …
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
…, AD Ho, MV Rosin, R Albertini, R Moratti… - Blood, The Journal …, 2014 - ashpublications.org
The kidney is involved in 70% of patients with immunoglobulin light-chain (AL) amyloidosis,
but little is known on progression or reversibility of renal involvement, and criteria for renal …
but little is known on progression or reversibility of renal involvement, and criteria for renal …
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL
…, L Obici, AR Bradwell, GVM D'Eril, R Fogari, R Moratti… - Blood, 2006 - ashpublications.org
N-terminal natriuretic peptide type B (NT-proBNP) is a marker of cardiac dysfunction in light
chain amyloidosis (AL) and a powerful prognostic determinant. Serum NT-proBNP and …
chain amyloidosis (AL) and a powerful prognostic determinant. Serum NT-proBNP and …
Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine
…, MS Graziani, GV Melzi D'Eril, R Moratti… - Clinical …, 2009 - academic.oup.com
Background: The diagnosis of systemic immunoglobulin light-chain (AL) amyloidosis requires
demonstration of amyloid deposits in a tissue biopsy and amyloidogenic monoclonal light …
demonstration of amyloid deposits in a tissue biopsy and amyloidogenic monoclonal light …
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy …
…, A Foli, LZ Bragotti, L Obici, R Moratti… - Blood, The Journal …, 2010 - ashpublications.org
… ), the shrinkage coefficient for calibration (measuring the accuracy of the model, ie, the
agreement between observed outcome and prediction), and the Royston explained variation (R 2 …
agreement between observed outcome and prediction), and the Royston explained variation (R 2 …
[HTML][HTML] Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma
…, C Paglino, F Tagliani, A Boncimino, R Moratti… - Annals of oncology, 2008 - Elsevier
Background A large amount of evidence suggests a possible role of interleukin-6 (IL-6) in the
pathogenesis of hepatocellular carcinoma (HCC). Patients and methods We studied both IL…
pathogenesis of hepatocellular carcinoma (HCC). Patients and methods We studied both IL…